BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide ...

February 21, 2023 | News

EmVenio prioritizes inclusion in clinical research with new patient-centric model

In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diver...

February 18, 2023 | News

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301.

In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is prou...

February 15, 2023 | News

Gilead to present data at APASL 2023 on effective models for monitoring and treating hepatitis C and efficacy of antiviral treatments for HIV-1 and HBV-coinfected adults

-- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with ...

February 15, 2023 | News

Syntach AB announces partnership with Meditrial CRO

Syntach AB ("Syntach") is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd ("Meditrial") to support the...

February 10, 2023 | News

Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease

The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10 In the maintenance phase, filgotinib ...

February 09, 2023 | News

Beyond Traditional Placebo Controls in Rare Disease Clinical Trials

The Collaborative Trajectory Analysis Project (cTAP), a global coalition in rare disease, has announced evidence to support patient-centric alternativ...

February 08, 2023 | News

Suvoda Introduces Extensible Software Platform Bringing Proven Tech Innovation to Clinical Trial Management

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...

February 07, 2023 | News

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. W...

February 02, 2023 | News

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...

February 02, 2023 | News

TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today repor...

February 01, 2023 | News

Bionomics Released Quarterly Activities and Cashflow Report

Released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 31 December 2022 (Quarter) and up to the date of this annou...

January 31, 2023 | News

DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore functi...

January 25, 2023 | News

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program

Avance Clinical made the announcement at Biotech Showcase 2023 where the team is taking meetings via PartnershipOne. "Given this successful early adoption ...

January 11, 2023 | News

Stay Connected